KesslerRC, BerglundP, DemlerO, et al.: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 2005; 62:593–602.
American Psychiatric AssociationDS, M-5 TaskForce, American Psychiatric AssociationPublishing. Diagnostic and statistical manual of mental disorders: DSM-5, 2017.
5.
FeldmanDB, PeriyakoilVS: Posttraumatic stress disorder at the end of life. J Palliat Med, 2006; 9:213–218.
6.
GlickDM, CookJM, MoyeJ, KaiserAP: Assessment and treatment considerations for post traumatic stress disorder at end of life. Am J Hosp Palliat Care, 2018; 35:1133–1139.
7.
GuinaJ, RossetterSR, DeRhodesBJ, et al.: Benzodiazepines for PTSD: A systematic review and meta-analysis. J Psychiatr Pract, 2015; 21:281–303.
8.
CookJM, McCarthyE, ThorpSR: Older adults with PTSD: Brief state of research and evidence-based psychotherapy case illustration. Am J Geriatr Psychiatry, 2017; 25:522–530.
9.
FeldmanDB, SoroccoKH, BratkovichKL: Treatment of posttraumatic stress disorder at the end-of-life: Application of the Stepwise Psychosocial Palliative Care model. Palliat Support Care, 2014; 12:233–243.
10.
SteinDJ, IpserJC, SeedatS: Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev, 2006; 1:CD002795.
11.
DavidsonJ, BaldwinD, SteinDJ, et al.: Treatment of posttraumatic stress disorder with venlafaxine extended release: A 6-month randomized controlled trial. Arch Gen Psychiatry, 2006; 63:1158–1165.
12.
SchneierFR, CampeasR, CarcamoJ, et al.: Combined Mirtazapine and SSRI treatment of PTSD: A placebo-controlled trial. Depress Anxiety, 2015; 32:570–579.
13.
DavidsonJRT, WeislerRH, ButterfieldMI, et al.: Mirtazapine vs. placebo in posttraumatic stress disorder: A pilot trial. Biol Psychiatry, 2003; 53:188–191.
14.
KungS, EspinelZ, LapidMI: Treatment of nightmares with prazosin: A systematic review. Mayo Clin Proc, 2012; 87:890–900.
15.
AkinsanyaA, MarwahaR, TampiRR: Prazosin in children and adolescents with posttraumatic stress disorder who have nightmares: A systematic review. J Clin Psychopharmacol, 2017; 37:84–88.
